Girish Venkatachaliah Joins as Chief Product & Technology Officer for Decision Resources Group

BURLINGTON, Mass., Sept. 26, 2019 /PRNewswire/ — Decision Resources Group (DRG), www.decisionresourcesgroup.com, a premier provider of data, analytics and insights products and services to the healthcare industry, today announced the appointment of Girish Venkatachaliah as its new Chief Product & Technology Officer. Girish will lead DRG’s continued development of AI enabled integrated solutions designed to help life sciences, payers, and providers understand and engage the healthcare consumer in ways that improve health outcomes. 

Girish joins DRG following his role as the Vice President of Data Strategy, Analytics and AI/ML at athenahealth where he led the strategy, research, product management, and engineering teams and pioneered unique uses of data and AI for provider efficiency. Prior to his role at athenahealth, Girish was the Vice President of product development at IBM responsible for a portfolio of cloud offerings including, Watson Machine Learning & persistence in the Watson Data Platform. Over his 17-year career at IBM, he held a variety of executive roles in the data, analytics and AI/ML.

“The addition of Girish’s extensive experience in Data and AI, coupled with his strong business leadership and strategic acumen, will be critical to our next level of success,” said Vivek Sharma, CEO DRG. “His deep knowledge of leading methods to solve healthcare challenges will serve to enhance our vision of advancing a global healthcare industry in which all organizations are insights and intelligence enabled. Together with our customers, we can speed up innovative treatments and better care.”

DRG has undergone a transformation from a syndicated market research company into a data-infused pioneer illuminating the challenges and opportunities present within the global healthcare ecosystem. This transformation has helped to accelerate business growth and expand product and services offerings for the fast-changing life sciences industry. DRG’s continuing investment in AI and machine learning on top of its platform of real-world data and industry leading insights positions the company to support the industry’s ever-growing need to engage with consumers in new ways, avoid barriers to access and adherence, and respond more quickly to unmet need.

To learn more about Decision Resources Group and Girish Venkatachaliah, visit https://decisionresourcesgroup.com/people/?role=executive-team&expertise=all.

About Decision Resources Group (DRG)

Decision Resources Group, a subsidiary of Piramal Enterprises Ltd., is uniquely positioned to help healthcare businesses improve the lives of patients around the world by creating patient-centric commercial strategies that drive better outcomes and better access. DRG helps clients propel commercial success with evidence-based business decisions by delivering expert consultation, data and analysis enhanced by machine learning artificial intelligence (AI). With collaborative experts spanning healthcare markets, disease areas, and data science disciplines, DRG clients have unprecedented access to the expertise, data and AI-technology solutions they need to anticipate customer needs, and generate new solutions to healthcare challenges. DRG’s market access solutions give life sciences the most comprehensive view of patient access, and payer and health system dynamics at local levels for the global healthcare ecosystem.

Media contact:

Catherine Daniel
Decision Resources Group
215-968-9926
cdaniel@teamdrg.com 

View original content to download multimedia:http://www.prnewswire.com/news-releases/girish-venkatachaliah-joins-as-chief-product–technology-officer-for-decision-resources-group-300925665.html

SOURCE Decision Resources Group

Staff

Recent Posts

AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd.

Strategic Expansion into Cardio AI-Driven Healthcare SolutionsCollaboration to Enhance Patient-Centered Digital Healthcare TechnologiesWelcomes Key Industry…

2 hours ago

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

16 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

17 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

17 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

18 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

20 hours ago